| CAS No. | 1841409-92-4 |
| Chemical Name | Chembl4440140 |
| Synonyms | Chembl4440140 |
| SMILES | Cl.OC[C@H]1[C@H](C2C=CC(=CC=2)CCCCCCCC)CCN1 |
| Formula | C19H32ClNO |
| M.Wt | 325.916484832764 |
| Purity | >97% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Shipping condition | Ships from Shanghai; packaging confirmed at order. |
| Publication | Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeutics-February 2023 Nucleic Acids Research DOI:10.1093/nar/gkad023 |
| Product classification | Small molecule tools for RNA delivery |

SH-BC-893
Pack size & price
USDDescription & Application
SH-BC-893 is a water-soluble, orally bioavailable synthetic sphingolipid that triggers nutrient transporter internalization and also blocks lysosome-dependent nutrient generation pathways in cancer cells, activates protein phosphatase 2A (PP2A), leading to mislocalization of the lipid kinase PIKfyve; selectively kills cells expressing an activated form of the anabolic oncogene Ras in vitro and in vivo.SH-BC-893, increases the activity of antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) up to 200-fold in vitro without permeabilizing endosomes. SH-BC-893 treatment trapped endocytosed oligonucleotides within extra-lysosomal compartments thought to be more permeable due to frequent membrane fission and fusion events. Simultaneous disruption of ARF6-dependent endocytic recycling and PIKfyve-dependent lysosomal fusion was necessary and sufficient for SH-BC-893 to increase non-lysosomal oligonucleotide levels and enhance their activity. In mice, oral administration of SH-BC-893 increased ASO potency in the liver by 15-fold without toxicity. More importantly, SH-BC-893 enabled target RNA knockdown in the CNS and lungs of mice treated subcutaneously with cholesterol-functionalized duplexed oligonucleotides or unmodified ASOs, respectively. Together, these results establish the feasibility of using a small molecule that disrupts endolysosomal trafficking to improve the activity of oligonucleotides in extrahepatic tissues.
Solution Calculators
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Quick preparation table
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 30.6827 mL | 6.1365 mL | 3.0683 mL |
| 25 mg | 76.7068 mL | 15.3414 mL | 7.6707 mL |
| 50 mg | 153.4135 mL | 30.6827 mL | 15.3414 mL |
| 100 mg | 306.8271 mL | 61.3654 mL | 30.6827 mL |
| 250 mg | 767.0677 mL | 153.4135 mL | 76.7068 mL |
Need a different pack size or technical document?
Contact our team with the catalog number and requested quantity.
